The Biden administration’s push to introduce widespread Covid-19 vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials.

The outside panel of about 20 scientific advisers is set to review information Friday about the Pfizer Inc. and BioNTech SE vaccine’s declining protection against Covid-19 over time and on how people tolerated additional doses. It will hear presentations from Pfizer, which has asked regulators to clear booster shots for people 16 years and older, and the FDA, which this week said all the shots cleared for use in the U.S. remain effective without boosters. The panel will also consider contrasting scientific data about the extra shots.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Meme stocks and a booming market: How household net worth doubled in the past decade

The net worth of U.S. households climbed to new heights as 2021…

Inflation seems stubborn, but people keep spending. What’s going on?

What’s consumers’ relationship with the economy these days? It’s complicated. As last…

The heaviest animal ever? Massive whale that lived 40 million years ago found in desert

Dating of volcanic ash at the site means the team could date…

Bucking the Pandemic, Austin Is ‘the Hottest Market in the Country’

AUSTIN, Texas — In March 2020, the outlook in Austin was bleak…